Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
CD-X - Development of new packaging technology for the prevention of side effects from products in the cosmetic sector
| Reference number | 2013-03446 |
| Coordinator | Chemotechnique MB Diagnostics Aktiebolag |
| Funding from Vinnova | SEK 500 000 |
| Project duration | November 2013 - November 2014 |
| Status | Completed |
